Presidential candidate and Minnesota Rep. Michele Bachmann (R) used two appearances on cable news to drive home her strongest moment in Monday's CNN-Tea Party Express presidential debate: her attack on Texas Gov. Rick Perry over his support for a controversial HPV vaccination program. 

Asked during the debate about Perry's decision to permit a law requiring teenage girls to be vaccinated against a sexually transmitted virus linked to cancer, Bachmann at first called it a violation of parents' rights. But then, as if recalling a zinger she had practiced earlier but forgotten in the heat of the debate, Bachmann asked moderator Wolf Blitzer for a chance to go again. 

That's when Bachmann made her most pointed allegation of the night, claiming Perry looked the other way because of a $5,000 campaign contribution and because his former chief of staff was the head lobbyist for the drug company that stood to benefit. 

"This is what people hate about politics," Bachmann doubled down after the debate on Fox News's "On the Record w/ Greta Van Susteren." "They use their position of power to benefit those political donors." 

Perry also raised eyebrows with his response to Bachmann during the debate, seeming to argue that $5,000 would never be enough to buy him off. 

"I received about $30 million. If you're saying I can be bought for $5,000, I'm offended," he said. 

On Fox News, Bachmann said a woman had come up to her crying after the debate, claiming her daughter had become mentally retarded after being administered the vaccine. 

"You've got to get it right the first time, and I have a core sense of conviction on these issues, and I would have never due that to innocent little girls," Bachmann said on CNN minutes after the debate concluded. 

The federal Centers for Disease Control and Prevention has studied potential complications from the vaccine and determined that the vast majority of adverse effects are non-serious. 

"Based on all of the information we have today, CDC recommends HPV vaccination for the prevention of most types of cervical cancer," the agency wrote.